Merck follows Bristol with EU green light for immune cancer drug
 

Merck follows Bristol with EU green light for immune cancer drug
(Reuters) - European regulators have recommended approval of Merck & Co Inc's immune system-boosting cancer drug Keytruda, following a similar green light last month for Bristol-Myers Squibb Co's rival product Opdivo.http://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1


http://da.feedsportal.com/r/22876621...21/rc/1/rc.img
http://da.feedsportal.com/r/22876621...21/rc/2/rc.img
http://da.feedsportal.com/r/22876621...21/rc/3/rc.img

http://da.feedsportal.com/r/22876621...b/sc/21/a2.img
http://adchoice.feedsportal.com/r/22.../sc/21/ach.imghttp://pi.feedsportal.com/r/22876621.../sc/21/a2t.imghttp://pi2.feedsportal.com/r/2287662...sc/21/a2t2.imghttp://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...-8:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...-8:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/3gRlBZcYI9A